Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200065332Phase 4Recruiting
Phase 4 trial of remimazolam in pain and None (2 arms), sponsored by Dongguan People's Hospital. Primary endpoint: QoR-15 score on postoperative day 1. Started Nov 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200065332.